263 related articles for article (PubMed ID: 30732631)
1. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.
Pineda M; Juríčková K; Karimzadeh P; Kolnikova M; Malinova V; Insua JL; Velten C; Kolb SA
Orphanet J Rare Dis; 2019 Jan; 14(1):32. PubMed ID: 30732631
[TBL] [Abstract][Full Text] [Related]
2. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
[TBL] [Abstract][Full Text] [Related]
3. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
[TBL] [Abstract][Full Text] [Related]
4. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.
Patterson MC; Mengel E; Vanier MT; Schwierin B; Muller A; Cornelisse P; Pineda M;
Orphanet J Rare Dis; 2015 May; 10():65. PubMed ID: 26017010
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
[TBL] [Abstract][Full Text] [Related]
6. Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study.
Pineda M; Wraith JE; Mengel E; Sedel F; Hwu WL; Rohrbach M; Bembi B; Walterfang M; Korenke GC; Marquardt T; Luzy C; Giorgino R; Patterson MC
Mol Genet Metab; 2009 Nov; 98(3):243-9. PubMed ID: 19656703
[TBL] [Abstract][Full Text] [Related]
7. Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study.
Freihuber C; Dahmani-Rabehi B; Brassier A; Broué P; Cances C; Chabrol B; Eyer D; Labarthe F; Latour P; Levade T; Pichard S; Sevin C; Vanier MT; Héron B
Orphanet J Rare Dis; 2023 Jul; 18(1):204. PubMed ID: 37480097
[TBL] [Abstract][Full Text] [Related]
8. Initiation and discontinuation of substrate inhibitor treatment in patients with Niemann-Pick type C disease.
Pérez-Poyato MS; Gordo MM; Marfa MP
Gene; 2012 Sep; 506(1):207-10. PubMed ID: 22750297
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series.
Pineda M; Perez-Poyato MS; O'Callaghan M; Vilaseca MA; Pocovi M; Domingo R; Portal LR; Pérez AV; Temudo T; Gaspar A; Peñas JJ; Roldán S; Fumero LM; de la Barca OB; Silva MT; Macías-Vidal J; Coll MJ
Mol Genet Metab; 2010 Apr; 99(4):358-66. PubMed ID: 20056559
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: A large retrospective observational study.
Patterson MC; Garver WS; Giugliani R; Imrie J; Jahnova H; Meaney FJ; Nadjar Y; Vanier MT; Moneuse P; Morand O; Rosenberg D; Schwierin B; Héron B
J Inherit Metab Dis; 2020 Sep; 43(5):1060-1069. PubMed ID: 32324281
[TBL] [Abstract][Full Text] [Related]
11. Miglustat in Niemann-Pick disease type C patients: a review.
Pineda M; Walterfang M; Patterson MC
Orphanet J Rare Dis; 2018 Aug; 13(1):140. PubMed ID: 30111334
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry.
Patterson MC; Mengel E; Vanier MT; Moneuse P; Rosenberg D; Pineda M
Orphanet J Rare Dis; 2020 Apr; 15(1):104. PubMed ID: 32334605
[TBL] [Abstract][Full Text] [Related]
13. Early miglustat therapy in infantile Niemann-Pick disease type C.
Di Rocco M; Dardis A; Madeo A; Barone R; Fiumara A
Pediatr Neurol; 2012 Jul; 47(1):40-3. PubMed ID: 22704015
[TBL] [Abstract][Full Text] [Related]
14. Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat.
Sedel F; Chabrol B; Audoin B; Kaphan E; Tranchant C; Burzykowski T; Tourbah A; Vanier MT; Galanaud D
J Neurol; 2016 May; 263(5):927-936. PubMed ID: 26984608
[TBL] [Abstract][Full Text] [Related]
15. Complete recovery from psychosis upon miglustat treatment in a juvenile Niemann-Pick C patient.
Szakszon K; Szegedi I; Magyar A; Oláh E; Andrejkovics M; Balla P; Lengyel A; Berényi E; Balogh I
Eur J Paediatr Neurol; 2014 Jan; 18(1):75-8. PubMed ID: 24119781
[TBL] [Abstract][Full Text] [Related]
16. Disease and patient characteristics in NP-C patients: findings from an international disease registry.
Patterson MC; Mengel E; Wijburg FA; Muller A; Schwierin B; Drevon H; Vanier MT; Pineda M
Orphanet J Rare Dis; 2013 Jan; 8():12. PubMed ID: 23324478
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of different suspicion indices in identifying patients with Niemann-Pick disease Type C in clinical practice: a post hoc analysis of a retrospective chart review.
Pineda M; Juríčková K; Karimzadeh P; Kolniková M; Malinová V; Torres J; Kolb SA
Orphanet J Rare Dis; 2019 Jul; 14(1):161. PubMed ID: 31266511
[TBL] [Abstract][Full Text] [Related]
18. Visceral symptoms as a key diagnostic sign for the early infantile form of Niemann-Pick disease type C in a Russian patient: a case report.
Degtyareva AV; Mikhailova SV; Zakharova EY; Tumanova EL; Puchkova AA
J Med Case Rep; 2016 Jun; 10(1):143. PubMed ID: 27250337
[TBL] [Abstract][Full Text] [Related]
19. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
[TBL] [Abstract][Full Text] [Related]
20. Molecular and biochemical biomarkers for diagnosis and therapy monitorization of Niemann-Pick type C patients.
Hammerschmidt TG; de Oliveira Schmitt Ribas G; Saraiva-Pereira ML; Bonatto MP; Kessler RG; Souza FTS; Trapp F; Michelin-Tirelli K; Burin MG; Giugliani R; Vargas CR
Int J Dev Neurosci; 2018 May; 66():18-23. PubMed ID: 29197565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
